25 May 2013
Keywords: gi, interleukin-12, study, stopped, genetics, institute, suspended
Article | 19 June 1995
Genetics Institute has suspended a Phase II study of its recombinant
interleukin-12 (rhIL-12) in patients with advanced kidney cancer after
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 June 1995
12 June 1995
24 May 2013
© 2013 thepharmaletter.com